Related Experiment Video
Updated: Jan 12, 2026
A Unified Methodological Framework for Vestibular Schwannoma Research
Published on: June 20, 2017
Loss of Enhancement in Vestibular Schwannomas Post Stereotactic Radiosurgery: Impact on Tumor Control and Serviceable
Prav Mehta1,2, Neetu Soni3, John C Benson2
1Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.
Objective:
Vestibular schwannomas (VSs) treated with stereotactic radiosurgery (SRS) often show transient loss of central tumor enhancement. We hypothesized that this loss of enhancement may correlate with better tumor control on follow-up imaging.
Methods:
We evaluated 198 consecutive patients from a single center who met eligibility criteria. Tumor volumes on the pre-SRS and post-SRS scans were quantified along with regions of loss of enhancement on the first post-SRS study. The latter was correlated with tumor volumes at follow-up, radiation isocenter density, and loss of serviceable hearing.
Results:
For the entire cohort, the median loss of enhancement on the first post-SRS scan was 14% (IQR: 6 to 25) and median rate of change in tumor volume was -4.5% per year (IQR: -10.5 to 1.5). Percent loss of central enhancement showed significant negative correlation with tumor growth not only for the entire cohort (correlation coefficient: -0.18, P =0.01), but also for the subset of patients who had available imaging until at least 2 years (n=185) and 4 years (n=179) post-SRS. Loss of enhancement also strongly correlated positively with tumor volumes and number of radiation isocenters and negatively with isocenter density. Finally, patients with greater percent loss of enhancement had an increased likelihood of progression to non-serviceable hearing, although this association was not statistically significant.
Conclusions:
These findings suggest that loss of central tumor enhancement in VSs post-SRS may be associated with improved tumor control.
